Inogen Inc has completed the sale of its U.S. oxygen rental business to Rotech Healthcare Inc. for an estimated total of $24.8 million. The transaction, finalized on November 2, 2026, is part of a strategic shift for Inogen, allowing the company to concentrate on its core operations in the orthopedic, prosthetic, and surgical appliances and supplies sector.

The sale includes specified on-rent and on-hand inventory along with related patient records. The purchase price is subject to post-closing reconciliation and will be paid in six installments.

In conjunction with this sale, Inogen also announced a leadership transition. Andrew P. Reding, previously the Chief Operating Officer, has been appointed as the new President and Chief Executive Officer, effective October 30, 2026. He succeeds Kevin R.M. Smith, whose tenure as CEO ended on the same date.

This leadership change comes at a pivotal moment for Inogen as it navigates the competitive landscape of the orthopedic and surgical appliance industry. The company aims to enhance its focus on core competencies while adapting to market demands.

Inogen's recent filing also included its financial results for the third quarter ended September 30, 2026. The company issued a press release detailing these results, which coincided with the completion of the sale of its U.S. rental business.

The implications of these changes could resonate throughout the industry, particularly as Rotech Healthcare expands its service offerings in the oxygen rental market.

Looking ahead, Inogen's focus will likely shift towards leveraging its remaining assets and enhancing operational efficiencies under the new leadership of Mr. Reding. The filing does not specify what happens next in terms of strategic initiatives or further corporate actions.